Medihealth (Northern) Limited
Registered name: MEDIHEALTH (NORTHERN) LIMITED
Medihealth (Northern) Limited made £86.1m revenue and £3.9m profit in the year to 31 Aug 2025. read from filing text
Medihealth (Northern) Limited’s revenue grew 57% to £86.1m in the year to 31 Aug 2025, with £3.9m profit and 11 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Bolton; we hold 2 years of its filed accounts.
- Status
- Active
- Location
- Bolton, North West
- Age
- 22 yrs · since 2004
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “The company is a wholly owned subsidiary of Makan Investments Limited. Makan Investments Limited is a company”
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Aug 2024 | 31 Aug 2025 |
|---|---|---|
| Disclosure | Full P&Lread from filing text | Full P&Lread from filing text |
| Profit & loss | ||
| Revenue (turnover) | £54.9m | £86.1m |
| Cost of sales | £49.8m | £78.9m |
| Gross profit | £5.1m | £7.2m |
| Operating profit | £3.4m | £5.2m |
| Profit before tax | £3.4m | £5.2m |
| Profit after tax | £2.5m | £3.9m |
| Profit (best available) | £2.5m | £3.9m |
| Staff costs | £589k | £643k |
| Employees (average) | 10 | 11 |
| Ratios | ||
| Profit margin | 4.6% | 4.6% |
| Gross margin | 9.3% | 8.4% |
| Revenue per employee | £5.5m | £7.8m |
| Profit per employee | £254k | £357k |
| Cash conversion | −32.8% | −28% |
| Growth (year on year) | ||
| Revenue growth | — | ▲56.9% |
| Profit growth | — | ▲54.6% |
| Headcount growth | — | ▲10% |
| Balance sheet — indirect signals, not revenue | ||
| Cash at bank | £294k | £432k |
| Net assets | £7.8m | £11.8m |
| Current assets | £12.4m | £22.6m |
| Debtors | £11.7m | £21.6m |
| Deferred income | £222k | £173k |
| Cash from operations | −£1.1m | −£1.5m |
| Source | FullAccounts · bulk data May 2026 | FullAccounts · bulk data May 2026 |
How the business works
- Profit margin
- 4.6%
- Profit ÷ revenue.
- Gross margin
- 8.4%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £7.8m
- Revenue ÷ average employees.
- Profit per employee
- £357k
- Profit ÷ average employees.
- Cash conversion
- −28%
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- 0.2%
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 25.1%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▲50%
- Now £11.8m
- Cash at bank
- ▲47%
- Now £432k
- Headcount
- ▲10%
- Now 11
- Deferred income
- ▼22%
- Now £173k
- Fixed assets
- —
- Now —
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Group structure
Subsidiaries (1)
- Northco Distribution LimitedFigures not disclosed
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- Eco Animal Health Group PLCLondon · Wholesale of pharmaceutical goods
- Revenue
- £87.5m
- Profit
- £3.7m
- Staff
- —
- C. S. T. Pharma LimitedWalsall · Wholesale of pharmaceutical goods
- Revenue
- £91.3m
- Profit
- £1.7m
- Staff
- 115
- P & a J Cattee (Wholesale) Ltd.Manchester · Wholesale of pharmaceutical goods
- Revenue
- £78.7m
- Profit
- £6m
- Staff
- 83
- Rayburn Trading Company LimitedSalford · Wholesale of pharmaceutical goods
- Revenue
- £98.5m
- Profit
- £2.3m
- Staff
- 188
- Steris Solutions LimitedBasingstoke · Wholesale of pharmaceutical goods
- Revenue
- £111m
- Profit
- £4m
- Staff
- 258
- Aspire Pharma LimitedGodalming · Wholesale of pharmaceutical goods
- Revenue
- £118m
- Profit
- £21.8m
- Staff
- 114
Sources
Latest figures from FullAccounts for the year to 31 Aug 2025 (profit £3.9m), from the Companies House accounts bulk data published May 2026. Spotted an error? Request a correction.
Updated from Companies House on 23 Oct 2026
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.